Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 402126, 9 pages
http://dx.doi.org/10.1155/2014/402126
Research Article

Pharmacokinetic Alteration of Baclofen by Multiple Oral Administration of Herbal Medicines in Rats

1School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 440-746, Republic of Korea
2Department of Rehabilitation Medicine, School of Medicine, Catholic University of Daegu, Daegu 705-718, Republic of Korea
3Department of Pharmacy, College of Pharmacy, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea
4College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongbuk 712-702, Republic of Korea
5Department of Cardiovascular and Neurologic Diseases, College of Oriental Medicine, Daegu Haany University, Daegu 706-060, Republic of Korea
6College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 406-840, Republic of Korea

Received 14 April 2014; Revised 9 August 2014; Accepted 9 August 2014; Published 29 October 2014

Academic Editor: Yuping Tang

Copyright © 2014 Tae Hwan Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Institute of Health, “Spasticity: MedlinePlus,” 2014, http://www.nlm.nih.gov/medlineplus/ency/article/003297.htm.
  2. C. Hughes and I. M. Howard, “Spasticity management in multiple sclerosis,” Physical Medicine and Rehabilitation Clinics of North America, vol. 24, no. 4, pp. 593–604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. G. Zhao, C. H. Cao, B. J. Han et al., “Effect of acupuncture treatment on spastic states of stroke patients,” Journal of the Neurological Sciences, vol. 276, no. 1, pp. 143–147, 2009. View at Publisher · View at Google Scholar
  4. N.-H. Yim, Y. P. Jung, A. Kim, C. J. Ma, W.-K. Cho, and J. Y. Ma, “Oyaksungisan, a traditional herbal formula, inhibits cell proliferation by induction of autophagy via JNK activation in human colon cancer cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 231874, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. C. Oh, W. K. Cho, J. H. Oh et al., “Fermentation by Lactobacillus enhances anti-inflammatory effect of Oyaksungisan on LPS-stimulated RAW 264.7 mouse macrophage cells,” BMC Complementary and Alternative Medicine, vol. 12, article 17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. T. Zhao, S. Y. Jeong, D. C. Moon, K. H. Son, J. K. Son, and M. H. Woo, “High performance liquid chromatography used for quality control of Achyranthis Radix,” Archives of Pharmacal Research, vol. 35, no. 8, pp. 1449–1455, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Shen, Y. Yuan, F. Ding, N. Hu, J. Liu, and X. Gu, “Achyranthes bidentata polypeptides confer neuroprotection through inhibition of reactive oxygen species production, bax expression, and mitochondrial dysfunction induced by overstimulation of N-methyl-D-aspartate receptors,” Journal of Neuroscience Research, vol. 88, no. 3, pp. 669–676, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Gong and N. J. Sucher, “Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development,” Phytomedicine, vol. 9, no. 5, pp. 478–484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. K.-A. Kim, J.-S. Lee, H.-J. Park et al., “The inhibitory effect of achyranthes bidentata radix extracts on cytochrome P450-catalyzed reactions in human liver microsomes,” Journal of Korean Oriental Medicine, vol. 24, no. 2, pp. 40–46, 2003. View at Google Scholar
  10. R. Tie, L. Ji, Y. Nan et al., “Achyranthes bidentata polypeptides reduces oxidative stress and exerts protective effects against myocardial ischemic/reperfusion injury in rats,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19792–19804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Vetrichelvan and M. Jegadeesan, “Effect of alcohol extract of Achyranthes aspera Linn. on acute and subacute inflammation,” Phytotherapy Research, vol. 17, no. 1, pp. 77–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Xu and K.-J. Chen, “Herb-drug interaction: an emerging issue of integrative medicine,” Chinese Journal of Integrative Medicine, vol. 16, no. 3, pp. 195–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Fugh-Berman, “Herb-drug interactions,” The Lancet, vol. 355, no. 9198, pp. 134–138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. M. L. Chavez, M. A. Jordan, and P. I. Chavez, “Evidence-based drug-herbal interactions,” Life Sciences, vol. 78, no. 18, pp. 2146–2157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Seo, J. H. Kim, and H. K. Shin, “Simultaneous analysis of six constituents in Oyaksungi-san using HPLC-PDA,” Formula Science, vol. 20, no. 2, pp. 37–46, 2012. View at Google Scholar
  16. Korea Institute of Oriental Medicine (KIOM), Oriental Medicine Advanced Searching Intergrated System (OASIS), http://oasis.kiom.re.kr/main.jsp.
  17. J. H. Lee, T. S. Kim, D. H. Kwak, and J. Y. Ma, “Study on acute toxicity of fermented Ohyaksungi-san (Wuyaoshunqi-san) extracts,” Journal of Society of Korean Medicine for Obesity Research, vol. 11, no. 2, pp. 25–32, 2011. View at Google Scholar
  18. D. H. Jang, D. S. Seo, J. S. Hong et al., “13-week repeated-dose toxicity test and genetic toxicity test of Achyranthes japonica Nakai,” The Annual Report of KFDA, KFDA Administration, 2008. View at Google Scholar
  19. T. H. Kim, S. Shin, J. C. Shin et al., “Liquid chromatography-tandem mass spectrometry determination of baclofen in various biological samples and application to a pharmacokinetic study,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 938, pp. 43–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. R. J. Bauer, S. Guzy, and C. Ng, “A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples,” AAPS Journal, vol. 9, no. 1, pp. E60–E83, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. B. Bulitta, A. Bingölbali, B. S. Shin, and C. B. Landersdorfer, “Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT,” AAPS Journal, vol. 13, no. 2, pp. 201–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. B. Bulitta and C. B. Landersdorfer, “Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models,” AAPS Journal, vol. 13, no. 2, pp. 212–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Brendel, E. Comets, C. Laffont, C. Laveille, and F. Mentré, “Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide,” Pharmaceutical Research, vol. 23, no. 9, pp. 2036–2049, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. Bulitta, S. B. Duffull, M. Kinzig-Schippers et al., “Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 7, pp. 2497–2507, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. W. Faigle and H. Keberle, “The chemistry and kinetics of Lioresal,” Postgraduate Medical Journal, vol. 48, pp. 5–9, 1972. View at Publisher · View at Google Scholar · View at Scopus
  26. G. M. Kochak, A. Rakhit, W. E. Wagner, F. Honc, L. Waldes, and R. A. Kershaw, “The pharmacokinetics of baclofen derived from intestinal infusion,” Clinical Pharmacology and Therapeutics, vol. 38, no. 3, pp. 251–257, 1985. View at Publisher · View at Google Scholar · View at Scopus
  27. E. D. Popova, M. N. Puzin, G. B. Kolyvanov, and A. A. Litvin, “Baclofen pharmacokinetics in rats,” Eksperimental'naia i Klinicheskaia Farmakologiia, vol. 58, no. 3, pp. 53–54, 1995. View at Google Scholar
  28. European Medicines Agency, Guideline on the Investigation of Drug Interactions, 2013.
  29. E. Liere, D. H. Lough, and C. K. Sleeth, “THe effect of ephedrine on the emptying time of the human stomach,” Journal of the American Medical Association, vol. 106, no. 7, pp. 535–536, 1936. View at Publisher · View at Google Scholar
  30. B. R. Mandac, E. A. Hurvitz, and V. S. Nelson, “Hyperthermia associated with baclofen withdrawal and increased spasticity,” Archives of Physical Medicine and Rehabilitation, vol. 74, no. 1, pp. 96–97, 1993. View at Google Scholar · View at Scopus
  31. M. Kofler and A. A. Leis, “Prolonged seizure activity after baclofen withdrawal,” Neurology, vol. 42, no. 3, part 1, pp. 697–698, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. W. E. Braunsdorf, H. D. Kuhlendahl, A. Volkheimer, C. Behrens, and K. Kleiter, “Continuous intrathecal baclofen-administration with implantable pump-systems in severe spasticity,” Neurochirurgia, vol. 33, supplement 1, pp. 16–19, 1990. View at Google Scholar · View at Scopus
  33. R. D. Penn and J. S. Kroin, “Continuous intrathecal baclofen for severe spasticity,” The Lancet, vol. 2, no. 8447, pp. 125–127, 1985. View at Google Scholar · View at Scopus
  34. K. S. Lewis and W. M. Mueller, “Intrathecal baclofen for severe spasticity secondary to spinal cord injury,” Annals of Pharmacotherapy, vol. 27, no. 6, pp. 767–774, 1993. View at Google Scholar · View at Scopus